PHARMRXER LTD

Company number 15508552 · Active

PHARMRXER LTD is a private limited company registered in LONDON, United Kingdom, incorporated on 20 Feb 2024. Its registered activity is other human health activities. Its latest published accounts for the period ending 28 Feb 2025 show equity of £13k, total assets of £17k. It has filed 1 set of accounts.

Company details

Company number
15508552 · official register
Status
Active
Legal form
Private Limited Company
Incorporated
20 Feb 2024 (3 years)
Registered address
W1T 5DB LONDON
Postcode area
London West
Activity
86900 Other human health activities
Industry
Human health activities
Accounts overdue
No

Insolvency and register events

No insolvency or liquidation events on record.

Annual accounts GBP

Period endPublishedTurnoverResultEquityTotal assetsCurrent liabilitiesCashEmployees
28 Feb 202515 Nov 2025– –£13k£17k £3,875–1

As published. Small companies often file a balance sheet only, so turnover and result can be missing.

Similar companies in London West

Questions about PHARMRXER LTD

What is the company number of PHARMRXER LTD?

PHARMRXER LTD is registered under company number 15508552 in the official register of United Kingdom. View it at the official register.

Is PHARMRXER LTD still active?

Yes. PHARMRXER LTD is registered as active (status: Active).

Has PHARMRXER LTD gone bankrupt or into insolvency?

No insolvency, bankruptcy or administration is recorded for PHARMRXER LTD in the official data.

When was PHARMRXER LTD founded?

PHARMRXER LTD was incorporated on 20 Feb 2024.

Where is PHARMRXER LTD registered?

PHARMRXER LTD's registered address is in W1T 5DB LONDON (London West), United Kingdom.

What do the latest accounts of PHARMRXER LTD show?

The latest published accounts (period ending 28 Feb 2025) show equity of £13k, total assets of £17k, 1 employees.

Data: Companies House – Free Company Data Product, Accounts Data Product, Public Data API (Contains public sector information licensed under the Open Government Licence v3.0.). Last updated 7 Nov 2026.